Return On Equity ratio Analysis of Bellicum Pharmaceuticals Inc - Deep Dive


Latest FY ROE
Period Ending - Dec-23


Very Poor ROE
Period Ending - Dec-22
-1.24

Very Poor ROE
Growth
%
Trailing Twelve Months ROE
Period Ending - Dec-23

0


Poor ROE
Most recent Quarter ROE
Period Ending - Sep-23

0


Poor ROE
ROE Analysis of Bellicum Pharmaceuticals Inc
ROE Ratio of Bellicum Pharmaceuticals Inc with value of 0 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in trailing twelve months.
ROE Ratio of Bellicum Pharmaceuticals Inc with value of 0 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in latest Quarter ending on Sep-23.
ROE Ratio of BLCM drastically fell by % this year.
ROE Ratio with value of 0 was highest in Year Dec-20 in last Five Years.
ROE Ratio of BLCM trending down for at least three Years.
Latest ROE Ratio with value of is lower than Average ROE of in last five years.
ROE of Bellicum Pharmaceuticals Inc is negative because of poor net profit in FY ended on Dec-23.
Other ROE Related Info of BLCM that may interest you.
Bellicum Pharmaceuticals Inc Overview
CodePricePrevious PricePrice ChangeSector
BLCM0.20110.2212 9.09 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund.   more ..
Return On Equity Formula
ROE Related Ratios
ReturnOnAssetNetProfitMargin
Tsr Profitability Index
Poor Profitability Stock
FY - Historical Return On Equity of Bellicum Pharmaceuticals Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
ROE-1.24-0.039800-143.16-108.42
Change %-3015.31 %0 %-32.04 %-51.22 %
You are view first 7 Records. Log in to view all 12 in Premium view
FY Chart of Return On Equity of Bellicum Pharmaceuticals Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)